About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
Older
27 Dec 2017
Kazia Therapeutics Ltd and Noxopharm Ltd
21 Dec 2017
EOY Guidance on 2018 NOX66 Clinical Development Strategy
19 Dec 2017
Section 708 Certificate
19 Dec 2017
Appendix 3B
14 Dec 2017
Response to ASX Price Query
12 Dec 2017
Appendix 3B
11 Dec 2017
Change of Registered Office
7 Dec 2017
Section 708 Certificate
7 Dec 2017
Appendix 3B
6 Dec 2017
NOX Open Briefing Corporate Presentation
1
2
3
4
5
6
7
8
9
Next
